DI TOMMASO, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 1.600
EU - Europa 1.044
AS - Asia 987
SA - Sud America 178
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.827
Nazione #
US - Stati Uniti d'America 1.572
CN - Cina 388
SG - Singapore 316
UA - Ucraina 172
IE - Irlanda 167
BR - Brasile 155
GB - Regno Unito 128
TR - Turchia 128
DE - Germania 120
IT - Italia 112
SE - Svezia 112
FR - Francia 96
FI - Finlandia 63
VN - Vietnam 56
IN - India 45
RU - Federazione Russa 28
CA - Canada 13
MX - Messico 13
PL - Polonia 10
AR - Argentina 9
CZ - Repubblica Ceca 9
HK - Hong Kong 8
JP - Giappone 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
BD - Bangladesh 6
EC - Ecuador 6
BE - Belgio 4
EU - Europa 4
ID - Indonesia 4
IR - Iran 4
NL - Olanda 4
ES - Italia 3
KR - Corea 3
LT - Lituania 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
CL - Cile 2
GR - Grecia 2
IQ - Iraq 2
PK - Pakistan 2
UY - Uruguay 2
AT - Austria 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
IL - Israele 1
KE - Kenya 1
MD - Moldavia 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 3.827
Città #
Jacksonville 237
Singapore 222
Chandler 218
Dublin 167
Dallas 121
Beijing 118
Ashburn 117
Southend 106
Nanjing 83
Princeton 82
Izmir 64
New York 59
The Dalles 54
Los Angeles 48
Cambridge 39
Munich 38
Dearborn 37
Santa Clara 33
Altamura 28
Nanchang 28
Tongling 28
Wilmington 26
Ho Chi Minh City 21
Ann Arbor 20
Hanoi 17
Shenyang 16
São Paulo 16
Norwalk 15
Washington 15
Turku 14
Buffalo 12
Denver 12
Grevenbroich 12
Tianjin 12
Chieti 10
Helsinki 10
Jinan 10
Kunming 10
Redondo Beach 10
Rio de Janeiro 9
Stockholm 9
Hong Kong 8
Tokyo 8
Torino 8
Warsaw 8
Brno 7
Camerino 7
Guangzhou 7
Hebei 7
Jiaxing 7
Lanzhou 7
Mexico City 7
Monmouth Junction 7
Orem 7
Atlanta 6
Boardman 6
Brooklyn 6
Campobasso 6
Falls Church 6
Frankfurt am Main 6
Fribourg 6
Hangzhou 6
Johannesburg 6
Leawood 6
Manchester 6
Montreal 6
Changsha 5
Charlotte 5
Chicago 5
Houston 5
Phoenix 5
Amsterdam 4
Ardabil 4
Bologna 4
Brasília 4
Brussels 4
Changchun 4
Montesilvano Marina 4
Palermo 4
Poplar 4
Salvador 4
San Francisco 4
San Mateo 4
Toronto 4
Augusta 3
Belo Horizonte 3
Borgomanero 3
Joinville 3
London 3
Ningbo 3
Nuremberg 3
Porto Alegre 3
Querétaro 3
Quito 3
San Vito Chietino 3
Taizhou 3
Teramo 3
Woodbridge 3
Zhengzhou 3
Al Ain City 2
Totale 2.494
Nome #
Increasing age at disability milestones among MS patients in the MSBase Registry 137
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 131
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 125
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 118
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 118
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 114
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 113
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 112
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 108
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 107
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 106
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 106
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 106
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 105
JCV-Ab serostatus in MS patients treated with Natalizumab 104
Nail loss after teriflunomide treatment: a new potential adverse event 100
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 98
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study 97
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 96
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 93
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 92
Epidural analgesia and caesarean delivery are not associated with post-partum relapses and disability in MS. 92
Natalizumab-associated PML-IRIS: the Chieti experience. 91
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 90
Intramedullary Spinal Cord Glioblastoma: An Uncommon Diagnosis 89
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 89
Epidural analgesia and caesarean delivery are not associated with post-partum relapses and disability in MS 89
Atypical presentation of Cadasil a diagnostic challenge 88
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 85
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 84
Pregnancy and fetal outcomes after Glatiramer acetate exposure in patients with Multiple Sclerosis 83
Tumor necrosis factor α blockade therapy in a case of resistant primary angiitis of the central nervous system 83
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 81
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 81
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 81
Stratify-2 Test in the clinical practice: results from a large multicentric italian database 79
Increased risk of disability progression after pregnancy in MS patients with active disease 76
Predictors of post-partum relapses and disability progression in Multiple Sclerosis 73
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs 65
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 62
Totale 3.847
Categoria #
all - tutte 15.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 0 0 0 0 43 1 0 19 12 32 3
2021/2022161 1 3 6 30 6 5 12 13 8 6 25 46
2022/2023545 43 92 28 44 68 110 33 28 67 8 14 10
2023/2024326 16 21 25 11 31 146 40 0 1 7 3 25
2024/2025661 43 68 66 3 7 23 20 34 51 46 135 165
2025/2026806 134 39 192 243 181 17 0 0 0 0 0 0
Totale 3.847